Guérin M, Dolphin P J, Chapman M J
Institut National de la Santé et de la Recherche Médicale (I.N.S.E.R.M), Unité 321, Hôpital de la Pitié, Paris, France.
Atherosclerosis. 1993 Dec;104(1-2):195-212. doi: 10.1016/0021-9150(93)90191-v.
Patients presenting with a familial deficiency of lecithin:cholesterol acyltransferase (LCAT) typically exhibit multiple quantitative and qualitative perturbations of apo B- and apo A-I-containing plasma lipoproteins. Marked particle heterogeneity has been detected over the low-density range (d = 1.019-1.063 g/ml), involving lipoprotein(X) (LP-X) and large molecular weight LDL (LM-LDL). We describe the chromatographic fractionation and characterization of the major particle species distributed within the low-density interval in a new French LCAT-deficient family. Detailed analyses of the plasma lipoprotein and apolipoprotein spectrum are reported. The plasma lipoproteins were enriched in unesterified cholesterol and phospholipids with markedly reduced concentrations of cholesteryl esters. By a combination of gel filtration and affinity chromatography on heparin-sepharose, the heterogeneous mixture of low-density particles was resolved into three distinct particle populations: LP-X (diameter 400 A) corresponding to LM-LDL, an apo A-I and albumin-containing particle similar to LP-X2 (diameter 300 A), and cholesteryl ester-deficient (0.9%) triglyceride-rich (58.4%) LDL containing apo B-100 (diameter 260-270 A). Use of affinity chromatography allowed separation of HDL-like particles (diameter 140-160 A) which were rich in free cholesterol (21.4%) and phospholipids (52.9%) and which were isolated in association with LP-X upon gel filtration chromatography. Ultracentrifugal density gradient analysis of plasma from the LCAT-deficient subject over a period of 3 years showed a net shift of the lipoprotein distribution in the low density range due to an increase in plasma LP-X levels. We propose that the presence of LP-X in the plasma is correlated with a progressive alteration in the renal function recently observed in this patient.
患有卵磷脂胆固醇酰基转移酶(LCAT)家族性缺乏症的患者通常表现出含载脂蛋白B和载脂蛋白A-I的血浆脂蛋白在多个数量和质量方面的异常。在低密度范围(d = 1.019 - 1.063 g/ml)检测到明显的颗粒异质性,涉及脂蛋白X(LP-X)和大分子量低密度脂蛋白(LM-LDL)。我们描述了一个新的法国LCAT缺乏症家族中分布在低密度区间内主要颗粒种类的色谱分离和特征。报告了对血浆脂蛋白和载脂蛋白谱的详细分析。血浆脂蛋白富含未酯化胆固醇和磷脂,胆固醇酯浓度显著降低。通过凝胶过滤和肝素琼脂糖亲和色谱相结合的方法,将低密度颗粒的异质混合物分离为三个不同的颗粒群体:对应于LM-LDL的LP-X(直径400 Å)、类似于LP-X2(直径300 Å)的含载脂蛋白A-I和白蛋白的颗粒,以及含载脂蛋白B-100(直径260 - 270 Å)的胆固醇酯缺乏(0.9%)且富含甘油三酯(58.4%)的低密度脂蛋白。使用亲和色谱法可分离出类似高密度脂蛋白的颗粒(直径140 - 160 Å),其富含游离胆固醇(21.4%)和磷脂(52.9%),并且在凝胶过滤色谱中与LP-X一起分离出来。对该LCAT缺乏症患者3年期间的血浆进行超速离心密度梯度分析显示,由于血浆LP-X水平升高,脂蛋白分布在低密度范围内发生了净转移。我们认为血浆中LP-X的存在与该患者最近观察到的肾功能进行性改变相关。